NCT Number: NCT02666872
Evaluation of an Intervention PROMOting VAccination in Maternity in Quebec
Vaccination greatly reduced mortality and morbidity from many preventable diseases. However, to avoid the resurgence of these diseases and the human drama associated, high vaccine coverage should be maintained in the population. Yet in Quebec, vaccine coverage (VC) in young children remains suboptimal, especially caused by a proportion of parents who are ambivalent about the safety and effectiveness of vaccines. In this context, the Provincial Immunization Committee developed in 2010 a Quebec's immunization promotion plan.
Therefore, our research team tested and validated across the Eastern Townships, a vaccination promotion concept by means of an educational intervention within maternities, based on motivational interviewing techniques. This intervention has not only significantly increased the intention of vaccination (+15%) within parents who had received the intervention but also increased their child vaccination coverage (+7.5% at 7 months). This is the purpose of the PROMOVAQ study (PROmotion of VAccination in Quebec) This research project evaluated the impact of an educational strategy based on motivational interviewing techniques within maternity ward on infants' VC. This strategy has been tested through a provincial study (Montreal, Quebec, Sherbrooke) including more than 2500 families.
At term, this research program will offer the Quebec's Health Ministry an optimal strategy for immunization awareness so that Quebec's children may grow healthy and thrive.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
CHU Sainte-Justine, Montreal, Quebec, Canada
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Parents of all infants born in each participating maternity hospitals
- In Sherbrooke, inclusion limited to parents residing in the region of the Eastern Townships
- In Québec, inclusion limited to parents residing in the National Capital region.
Exclusion criteria
- Minor parents
- Parents who do not speak English or French
- Any health condition of the child or the mother needing acute care. That is to say, if the child must be hospitalized in neonatology, or if the mother has an incompatible condition with an interview.
Treatment and study plan
Primary outcomes
-
Vaccination status of the child at 7 months of age
Time frame: 10 months
Data was collected at 10 months of age for all children from regional immunization registries or self-reported by parents over the phone. Vaccination coverage is then defined by the number of infants who received all recommended childhood vaccines at 7 months of age by the total number of children.
Secondary outcomes
-
Vaccination status of the child at 3 and 5 months of age
Time frame: 10 months
Data was collected at 10 months of age for all children from regional immunization registries or self-reported by parents over the phone. Early vaccination coverage is then defined by the number of infants who received all recommended childhood vaccines at 3 and 5 months of age by the total number of children.
-
Vaccination status of the child at 13, 19 and 24 months of age
Time frame: 24 months
Data will be collected at 24 months of age for all children from regional immunization registries or self-reported by parents over the phone. Long-term vaccination coverage is then defined by the number of infants who received all recommended childhood vaccines at 13, 19 and 24 months of age by the total number of children.
-
Intention's parents to vaccination assessed by a questionnaire based on the Health Belief Model
Time frame: Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention
-
Hesitancy 's parents to vaccination by a questionnaire based on the Opel's tool to measure vaccine hesitancy
Time frame: Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention
Sponsors and collaborators
Lead sponsor
Université de Sherbrooke
Other
Collaborators
- CHU de Quebec-Universite Laval
- Fonds de la Recherche en Santé du Québec
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- St. Justine's Hospital
Registry information
Official study title
Evaluation of a New Educational Strategy Promoting Vaccination in Maternity in Quebec Based on Motivational Interviewing Techniques: PROMOVAQ Study
Acronym: PROMOVAQ
Important dates
- Study start
- 2013
- Primary completion
- 2015
- Study completion
- 2019
- First posted
- Jan 28, 2016
- Registry last updated
- Apr 27, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Impact of Education Methods on HPV Knowledge and Screening Behavior
NCT07017387
Adherence Interventions, Behavior
Ankara, Kecioren, Turkey (Türkiye)
View Trial DetailsMotivational Interviewing and Practice of Physical Activity in Patients With ALD
NCT06235307
Chronic Disease, Disease Attributes
Amiens, Picardie, France
View Trial DetailsThe Effect of Motivational Interviewing on Patients With Lumbar Discectomy
NCT07169955
Lumbar Disc Surgery, Motivational Interviewing
Ankara, Turkey (Türkiye)
View Trial DetailsThe Effect of Motivational Interviewing on Self-Efficacy and Quality of Life in Gestational Diabetes Mellitus
NCT06243939
Diabetes Mellitus, Diabetes, Gestational
Adana, Sarıçam, Turkey (Türkiye)
View Trial Details